Visit the Website for Patients 
Français
Subscribe to our newsletter!
Follow the latest news from CATALIS and Clinical Trials Quebec
25-36 of 39 results
Sort by
www.molecularforecaster.com
MFI is a computational chemistry company specializing in drug discovery, quantum mechanics, molecular dynamics, cheminformatics, and artificial intelligence. Offering proprietary software, algorithms, and contract research services, MFI collaborates with organizations to accelerate preclinical drug discovery for small molecules, from biotech startups to established pharmaceutical companies.
Discovery Services IT Services
www.nanofacile.bio/
We accelerate RNA-based therapy development. Nanofacile, a Montreal-based biotech startup, develops innovative RNA encapsulation solutions. Leveraging leading innovation hubs, the company aims to make RNA research and therapies more accessible and effective.
Discovery Services
CRO services supporting grants, financial/budget structures, startup implementation, strategic planning, partnerships & alliances, annual reporting, regulatory affairs, preclinical/clinical studies – customized boutique services.
Management and Support Services Consulting Services Discovery Services
www2.pqegroup.com/
A multinational quality and compliance services group for life sciences companies, specializing in data integrity, digital governance, engineering and qualification, quality and compliance, regulatory affairs, lab excellence, pharmacovigilance, audits, and training.
Management and Support Services Consulting Services IT Services
www.rd-biotech.com/en/
CRO/CDMO providing development and bioproduction services for biological tools and raw materials required in cell therapy, gene therapy, immunotherapy programs, and other projects needing plasmid DNA, monoclonal antibodies, or recombinant proteins. RD-Biotech is a French biotech with over 20 years of expertise.
Dosage Forms
rmtbiopharma.com/en/
A pharmaceutical company providing CDMO, CMO, and bioanalytical services, including TK/PK reporting.
Consulting Services Discovery Services Laboratory Services Dosage Forms
seriant.org/en
Seriant, a division of the Montreal Heart Institute, is a clinical research organization that provides comprehensive services to the pharmaceutical, medical device, and biotechnology industries, as well as to the academic community. Based in Montreal, Seriant operates internationally, supporting Phase I to IV clinical trials across a wide range of therapeutic areas. With our proven expertise in the development of innovative therapies, we help make a meaningful impact on people’s lives around the world.
Management and Support Services Consulting Services IT Services
scimega.com/
Scimega is a Canadian clinical research organization specializing in oncology, conducting cutting-edge oncology trials for medium and small biotech companies globally. With expertise in collaboration with suppliers, Scimega ensures fast site start-up and optimal patient recruitment without compromising data quality. Its operational design is robust enough to adapt to evolving clinical trial environments.
Management and Support Services
www.sgs.com/en-ca
We provide advanced services in GMP/GCP analyses, formulation R&D, clinical manufacturing, and clinical research for pharmaceutical, biopharmaceutical, and medical device sectors. Our solutions cover biologics and small molecules throughout the full lifecycle: development, testing, regulatory support, safety studies, clinical development, commercial QC, and post-market testing.
Consulting Services Discovery Services Laboratory Services
sorintellisgroup.com
Sorintellis leverages explainable AI to optimize drug development, providing actionable insights for better, more confident decision-making. Sorintellis solutions target clinical trial risk management and pharmaceutical portfolio management, serving CROs, pharma/biotech companies, and life sciences investment funds.
Consulting Services IT Services
pharmalube.com/en/
PharmaLube develops LubriumMC, a high-performance lubricating biomaterial with potential applications in osteoarthritis treatment, dry eye, and other therapeutic, cosmetic, and industrial uses.
www.theomedical.ca/en
THEO Medical is an innovative player in pharmaceutical clinical research and the collection of blood products for research. We specialize in conducting clinical trials for pharmaceutical, biotechnology, and medical device companies.
Management and Support Services IT Services Laboratory Services
Molecular Forecaster
Organization Contact Information
-
2075 Boulevard Robert-Bourassa, Suite 910, Montréal, QC H3A 2L1 -
-
-
Business Development Manager Contact Information
-
Josh Pottel -
CEO -
Member of
-
In Quebec: Head Office,Quebec-based SME -
Worldwide: 11-50 employees | Quebec: 11-50 employees -
Areas: North America, South America, Europe, Middle East, Africa, Asia-Pacific -
Customers: Startup, SME
MFI is a computational chemistry company specializing in drug discovery, quantum mechanics, molecular dynamics, cheminformatics, and artificial intelligence. Offering proprietary software, algorithms, and contract research services, MFI collaborates with organizations to accelerate preclinical drug discovery for small molecules, from biotech startups to established pharmaceutical companies.
Key Collaborations/Partnerships
Partnerships with NMX Research and Solutions (Quebec) and Oxeltis (France) to optimize research components related to drug design.
Services
Discovery Services IT Services
ChemistryPharmacokinetics and metabolismPharmacology
Artificial Intelligence (AI)
Expertise
Service offering independent of therapeutic area expertise
Small moleculesRNA therapiesRadiopharmaceutical
Preclinical
Other services
Computer-Aided Drug Design (CADD)
Nanofacile Inc.
Organization Contact Information
-
1250 Rue Guy, Suite 600, Montréal, QC H3H 2S7
-
-
-
Business Development Manager Contact Information
-
Ruben Rodrigo Lopez Salazar
-
CEO
-
Member of
-
In Quebec: Quebec-based SME
-
Worldwide: 1-10 employees | Quebec: 1-10 employees
-
Areas: North America
-
Customers: Startup, SME
We accelerate RNA-based therapy development. Nanofacile, a Montreal-based biotech startup, develops innovative RNA encapsulation solutions. Leveraging leading innovation hubs, the company aims to make RNA research and therapies more accessible and effective.
Key Collaborations/Partnerships
Concordia University, McGill University
Services
Discovery Services
Formulation
Expertise
Service offering independent of therapeutic area expertise
RNA therapiesNanotechnologies
Preclinical
NorthStar InnoVention
Organization Contact Information
-
66 Rue du Blizzard, Orford, QC, J1X 7E6
-
-
Business Development Manager Contact Information
-
Bruno Battistini
-
Principal & Senior Advisor
-
-
In Quebec: Head Office,Quebec-based SME
-
Worldwide: 1-10 employees | Quebec: 1-10 employees
-
Areas: North America
-
Customers: Startup
CRO services supporting grants, financial/budget structures, startup implementation, strategic planning, partnerships & alliances, annual reporting, regulatory affairs, preclinical/clinical studies – customized boutique services.
Key Collaborations/Partnerships
Academic institutions, health systems, research centers/institutes, biotechnology, medtech, biopharmaceutical, e-health, m-health
Services
Management and Support Services Consulting Services Discovery Services
Site Management & MonitoringDecentralized and Virtual trial servicesEthics review servicesMedical writing & Translation servicesRegulatory affairs & Quality systems
Business DevelopmentLicensing & StrategyProject & Process ManagementTraining & Recruiting
BiologyIND-enabling studiesPharmacokinetics and metabolismPharmacologyToxicology
Expertise
Allergy & Respiratory healthCardiovascularDermatologyEndocrinology & Metabolic disordersOncology & HematologyRare DiseasesService offering independent of therapeutic area expertise
Small moleculesService offering independent of scientific platform expertise
PreclinicalEarly phase research (I / I/II)Late phase research (II/III)Service offering independent of study type expertise
PQE Canada
Organization Contact Information
-
6050 Boulevard des Grandes-Prairies, Suite 205, Montréal, QC H1P 1A2
-
-
-
Business Development Manager Contact Information
-
Carlo Candotti
-
Vice President, Business Development – Francophone Region
-
Member of
-
In Quebec: Canadian Subsidiary
-
Worldwide: 251+ employees | Quebec: 1-10 employees
-
Areas: North America, South America, Europe, Middle East, Africa, Asia-Pacific
-
Customers: Startup, SME, Multinational
A multinational quality and compliance services group for life sciences companies, specializing in data integrity, digital governance, engineering and qualification, quality and compliance, regulatory affairs, lab excellence, pharmacovigilance, audits, and training.
Key Collaborations/Partnerships
International: QUINTIAN PHARMA, CQC (Glocal Quality Cannabis), Conceptio Provincial: BIOQuébec
Certifications
ISO/IEC 27001:2022 Certified QMS ISO 9001
Services
Management and Support Services Consulting Services IT Services
Data management & BiostatisticsSite Management & MonitoringDecentralized and Virtual trial servicesEthics review servicesFunctional Service Provider (FSP)Government & Public Health ServicesLogistics & Clinical supply managementMedical affairsMedical writing & Translation servicesPatient recruitmentSafety & PharmacovigilancePhase I Clinical Research Unit (CRU) - Healthy volunteersPhase I Clinical Research Unit (CRU) - Specialized patient populations or patients impacted by diseaseReal World EvidenceRegulatory affairs & Quality systems
Project & Process ManagementTraining & Recruiting
Artificial Intelligence (AI)Cardiac solutionsElectronic Clinical Outcome Assessments (eCOA)ImagingInteractive Response Technology (IRT)Respiratory solutionselectronic Trial Master File (eTMF)Wearables & connected devices
Expertise
Service offering independent of therapeutic area expertise
Small moleculesBiotechnologies and biotherapiesGene therapyCell therapyVaccineRNA therapiesNanotechnologiesRadiopharmaceuticalService offering independent of scientific platform expertise
Biosimilars & BioequivalenceIn vitro & Companion diagnosticsMedical Devices & Medical technologyPhase IV clinical trials & post-approvalPreclinicalGenericsPrecision medicineTranslational medicineEarly phase research (I / I/II)Late phase research (II/III)Service offering independent of study type expertise
Other services
Commissioning, Qualification and Validation (CQV), Digital Governance, Audits
RD-BIOTECH
Organization Contact Information
-
Technopole TEMIS Santé, 18 Rue Françoise-Dolto, 25000 Besançon, France / Montréal Office: CCIFC, 1455 Rue Drummond, Office 2B, Montréal, QC H3G 1W3
-
-
-
Business Development Manager Contact Information
-
Killian Brillet
-
Business Developer, North America
-
Member of
-
In Quebec: Canadian Subsidiary
-
Worldwide: 11-50 employees | Quebec: 1-10 employees
-
Areas: North America, Europe, Middle East, Africa
-
Customers: Startup, SME, Multinational
CRO/CDMO providing development and bioproduction services for biological tools and raw materials required in cell therapy, gene therapy, immunotherapy programs, and other projects needing plasmid DNA, monoclonal antibodies, or recombinant proteins. RD-Biotech is a French biotech with over 20 years of expertise.
Certifications
ISO 9001
Services
Dosage Forms
Bioproduction
Expertise
Service offering independent of therapeutic area expertise
Biotechnologies and biotherapiesGene therapyCell therapyVaccineRNA therapies
Service offering independent of study type expertise
Other services
Engineering and production services for plasmid DNA (Research Grade to GMP), antibodies and recombinant proteins, raw materials within R&D programs up to clinical phases (DNA): RNA therapies, DNA therapies, viral vectors, CAR-T cells. Bioproduction, plasmid DNA, recombinant antibodies, CRO, CDMO
Royalmount Laboratories, Pharmascience Inc.
Organization Contact Information
-
6111 Avenue Royalmount, Montréal, QC H4P 2T4
-
-
-
Business Development Manager Contact Information
-
John Chapdelaine
-
Director Business Development
-
Member of
-
In Quebec: Global Head Office,Quebec-based SME
-
Worldwide: 251+ employees | Quebec: 251+ employees
-
Areas: North America
-
Customers: Startup, SME, Biotech
A pharmaceutical company providing CDMO, CMO, and bioanalytical services, including TK/PK reporting.
Key Collaborations/Partnerships
Support for drug discovery as well as preclinical and clinical development for over 50 biotechnology companies.
Certifications
GLP, GCP, GMP SCC certified, FDA audited
Services
Consulting Services Discovery Services Laboratory Services Dosage Forms
Project & Process Management
BioanalysisFormulationIND-enabling studiesPharmacokinetics and metabolismToxicology
Assay development & validationBioanalysis
TabletsCapsulesSolutions and suspensionsInjectables
Expertise
Allergy & Respiratory healthCardiovascularCentral nervous systemDermatologyEndocrinology & Metabolic disordersGI & HepatologyImmunology & RheumatologyInfectious diseasesNephrologyOncology & HematologyOpthalmologyPediatricsRare DiseasesUrologyWomen's healthService offering independent of therapeutic area expertise
Small moleculesBiotechnologies and biotherapiesGene therapyCell therapyVaccineRNA therapies
Biosimilars & BioequivalenceMedical Devices & Medical technologyPreclinicalGenericsPrecision medicineTranslational medicineEarly phase research (I / I/II)Late phase research (II/III)
Other services
Bioanalysis and TK/PK reports audited by the FDA and compliant with ICH M10 standards
Seriant
Organization Contact Information
-
4945 Rue Beaubien East, Montréal, QC H1T 1V1
-
-
-
Business Development Manager Contact Information
-
Sophie Tanguay
-
Executive Director
-
Member of
-
In Quebec: Head Office
-
Worldwide: 51-250 employees | Quebec: 51-250 employees
-
Areas: North America, South America, Europe, Middle East, Africa, Asia-Pacific
-
Customers: SME
Seriant, a division of the Montreal Heart Institute, is a clinical research organization that provides comprehensive services to the pharmaceutical, medical device, and biotechnology industries, as well as to the academic community. Based in Montreal, Seriant operates internationally, supporting Phase I to IV clinical trials across a wide range of therapeutic areas. With our proven expertise in the development of innovative therapies, we help make a meaningful impact on people’s lives around the world.
Key Collaborations/Partnerships
Several international partners.
Services
Management and Support Services Consulting Services IT Services
Data management & BiostatisticsSite Management & MonitoringClinical research or site networkDecentralized and Virtual trial servicesFunctional Service Provider (FSP)Logistics & Clinical supply managementMedical affairsMedical writing & Translation servicesSafety & PharmacovigilancePhase I Clinical Research Unit (CRU) - Healthy volunteersPhase I Clinical Research Unit (CRU) – Specialized patient populations or patients impacted by diseaseReal World EvidenceRegulatory affairs & Quality systems
Project & Process ManagementTraining & Recruiting
Electronic Clinical Outcome Assessments (eCOA)Interactive Response Technology (IRT)
Expertise
Allergy & Respiratory healthCardiovascularCentral nervous systemDermatologyEndocrinology & Metabolic disordersGI & HepatologyImmunology & RheumatologyInfectious diseasesOncology & HematologyPediatricsService offering independent of therapeutic area expertise
Small moleculesBiotechnologies and biotherapiesVaccineRNA therapiesService offering independent of scientific platform expertise
Medical Devices & Medical technologyPhase IV clinical trials & post-approvalPrecision medicineEarly phase research (I / I/II)Late phase research (II/III)Service offering independent of study type expertise
Scimega
Organization Contact Information
-
3055 Boulevard Saint-Martin West, Suite T500, Laval, QC H7T 0J3
-
-
-
Business Development Manager Contact Information
-
Julie Martin
-
President & CEO
-
Member of
-
In Quebec: Head Office
-
Worldwide: 11-50 employees | Quebec: 1-10 employees
-
Areas: North America
-
Customers: Medium-sized Oncology Biotech Company
Scimega is a Canadian clinical research organization specializing in oncology, conducting cutting-edge oncology trials for medium and small biotech companies globally. With expertise in collaboration with suppliers, Scimega ensures fast site start-up and optimal patient recruitment without compromising data quality. Its operational design is robust enough to adapt to evolving clinical trial environments.
Key Collaborations/Partnerships
The LEAN Six Sigma Company, McPeak Sirois, SPharm
Services
Management and Support Services
Site Management & MonitoringPatient recruitmentSafety & PharmacovigilancePhase I Clinical Research Unit (CRU) - Healthy volunteersPhase I Clinical Research Unit (CRU) - Specialized patient populations or patients impacted by diseaseReal World EvidenceRegulatory affairs & Quality systems
Expertise
Oncology & Hematology
Small moleculesBiotechnologies and biotherapiesGene therapyCell therapyVaccineRNA therapiesNanotechnologiesRadiopharmaceutical
Medical Devices & Medical technologyPhase IV clinical trials & post-approvalEarly phase research (I / I/II)Late phase research (II/III)
Other services
Site selection and accelerated study start-up; provincial ethics approval strategy; Health Canada regulatory strategy; country monitoring; audit and GCP compliance consulting; full range of Scimega360 services
SGS Canada Inc.
Organization Contact Information
-
6490 Vipond Drive, Mississauga, ON L5T 1W8
-
-
-
Business Development Manager Contact Information
-
Jason Miraldo
-
Business Development Manager
-
Member of
-
In Quebec: Quebec-based SME
-
Worldwide: 251+ employees | Quebec: 1-10 employees
-
Areas: North America, South America, Europe, Middle East, Africa, Asia-Pacific
-
Customers: Multinational
We provide advanced services in GMP/GCP analyses, formulation R&D, clinical manufacturing, and clinical research for pharmaceutical, biopharmaceutical, and medical device sectors. Our solutions cover biologics and small molecules throughout the full lifecycle: development, testing, regulatory support, safety studies, clinical development, commercial QC, and post-market testing.
Key Collaborations/Partnerships
PSD, LSO, BIOQuébec, PDA
Certifications
GMP, GLP, ISO 17025
Services
Consulting Services Discovery Services Laboratory Services
Training & Recruiting
BioanalysisChemistry
Assay development & validationBioanalysisCentral laboratory servicesSpecialty laboratory services
Expertise
Service offering independent of therapeutic area expertise
Small moleculesBiotechnologies and biotherapiesGene therapyCell therapyVaccineRNA therapiesNanotechnologies
Biosimilars & BioequivalenceIn vitro & Companion diagnosticsGenericsLate phase research (II/III)
Sorintellis
Organization Contact Information
-
1050 Côte du Beaver Hall, Suite 1540, Montréal, QC H2Z 0A5
-
-
-
Business Development Manager Contact Information
-
Emmanuel Piffo
-
CEO & Founder
-
Member of
-
In Quebec: Head Office,Quebec-based SME
-
Worldwide: 1-10 employees | Quebec: 1-10 employees
-
Areas: North America, South America, Europe, Middle East, Africa
-
Customers: Startup, SME, Multinational, Nonprofit
Sorintellis leverages explainable AI to optimize drug development, providing actionable insights for better, more confident decision-making. Sorintellis solutions target clinical trial risk management and pharmaceutical portfolio management, serving CROs, pharma/biotech companies, and life sciences investment funds.
Services
Consulting Services IT Services
Project & Process Management
Artificial Intelligence (AI)
Expertise
Service offering independent of therapeutic area expertise
Small moleculesBiotechnologies and biotherapiesVaccine
Early phase research (I / I/II)Late phase research (II/III)
Other services
The Sorintellis platform allows users to input various data and generate accurate forecasts on clinical trial success probability. A priori forecasting of trial performance can help sponsors avoid failures or delays due to preventable events. Additionally, explainable machine learning used by the platform anticipates future events and enables appropriate corrective actions to mitigate risks during clinical trial planning and execution. Our solutions are targeted to Contract Research Organizations (CROs), pharmaceutical and biotech companies, and life sciences investment funds.
Technologies PharmaLube Inc.
Organization Contact Information
-
230 Rue Sherbrooke East, Suite 302, Montréal, QC H2X 1E1
-
-
-
Business Development Manager Contact Information
-
Bertrand Bolduc
-
President
-
Member of
-
In Quebec: Quebec-based SME
-
Worldwide: 1-10 employees | Quebec: 1-10 employees
-
Areas: North America
-
Customers: Startup
PharmaLube develops LubriumMC, a high-performance lubricating biomaterial with potential applications in osteoarthritis treatment, dry eye, and other therapeutic, cosmetic, and industrial uses.
Expertise
GI & HepatologyImmunology & RheumatologyOpthalmologyWomen's health
Service offering independent of scientific platform expertise
PreclinicalEarly phase research (I / I/II)
THEO Medical
Organization Contact Information
-
2758 Rue de Salaberry, Montréal, QC H3M 1L3
-
-
-
Business Development Manager Contact Information
-
Alain-Steve Theodat
-
President
-
Member of
-
In Quebec: Head Office,Quebec-based SME
-
Worldwide: 11-50 employees | Quebec: 11-50 employees
-
Areas: North America
-
Customers: Startup, SME, Multinational, Nonprofit
THEO Medical is an innovative player in pharmaceutical clinical research and the collection of blood products for research. We specialize in conducting clinical trials for pharmaceutical, biotechnology, and medical device companies.
Services
Management and Support Services IT Services Laboratory Services
Clinical research or site networkPatient recruitmentPhase I Clinical Research Unit (CRU) - Specialized patient populations or patients impacted by diseaseReal World Evidence
Artificial Intelligence (AI)Electronic Clinical Outcome Assessments (eCOA)
Biospecimen services
Expertise
Allergy & Respiratory healthCardiovascularEndocrinology & Metabolic disordersGI & HepatologyImmunology & RheumatologyInfectious diseasesOncology & HematologyRare DiseasesUrologyWomen's healthService offering independent of therapeutic area expertise
Biotechnologies and biotherapiesVaccineRNA therapiesService offering independent of scientific platform expertise
Phase IV clinical trials & post-approvalPreclinicalEarly phase research (I / I/II)Late phase research (II/III)Service offering independent of study type expertise
Other services
Collection of blood products (blood, serum, plasma, cells)
Your organization's information has changed?
Contact sponsors@clinicaltrialsquebec.com.